NLRP3 and metabolic dysfunction-associated steatohepatitis: Although many researched have been performed to explore the therapeutic effect and mechanism of BBR in diseases, its effect on NLRP3 inflammasome-mediated pyroptosis in NASH and the mechanism whereby this occurs, remain unknown.